Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 5 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 3 completed trials have results

Key Signals

1 recruiting

Enrollment Performance

Analytics

N/A
4(80.0%)
Phase 2
1(20.0%)
5Total
N/A(4)
Phase 2(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (5)

Showing 5 of 5 trials
NCT04040387Not ApplicableCompleted

NightWare Randomized Trial 02

Role: lead

NCT06399874Phase 2Recruiting

Nightmare Deconstruction and Reprocessing vs. NightWare Wristband

Role: collaborator

NCT03934658Not ApplicableCompleted

Remote Study of NightWare for PTSD With Nightmares

Role: lead

NCT03828656Not ApplicableUnknown

NightWare Open Enrollment Study

Role: lead

NCT03795987Not ApplicableCompleted

Traumatic Nightmares Treated by NightWare (To Arouse Not Awaken)

Role: lead

All 5 trials loaded